Cargando…
Discontinuation of antiepileptic drugs in adults with epilepsy
Patients with epilepsy who have been free of seizures for at least two years may be able to stop their antiepileptic drugs. Discontinuation may be considered after an individualised harm–benefit assessment and consultation with a neurologist is recommended. It is paramount to discuss with patients w...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075746/ https://www.ncbi.nlm.nih.gov/pubmed/33911333 http://dx.doi.org/10.18773/austprescr.2021.005 |
_version_ | 1783684580212998144 |
---|---|
author | Laue-Gizzi, Hanka |
author_facet | Laue-Gizzi, Hanka |
author_sort | Laue-Gizzi, Hanka |
collection | PubMed |
description | Patients with epilepsy who have been free of seizures for at least two years may be able to stop their antiepileptic drugs. Discontinuation may be considered after an individualised harm–benefit assessment and consultation with a neurologist is recommended. It is paramount to discuss with patients whether the risk of seizure recurrence is worth the benefit of stopping the antiepileptic drug. The risk of seizure recurrence after antiepileptic drugs are discontinued depends on the epilepsy syndrome and a number of other risk factors. Approximately 30–50% of patients will relapse. If seizures recur, the majority of patients regain seizure control when treatment is resumed. However up to 20% do not achieve immediate remission. |
format | Online Article Text |
id | pubmed-8075746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-80757462021-04-27 Discontinuation of antiepileptic drugs in adults with epilepsy Laue-Gizzi, Hanka Aust Prescr Aricle Patients with epilepsy who have been free of seizures for at least two years may be able to stop their antiepileptic drugs. Discontinuation may be considered after an individualised harm–benefit assessment and consultation with a neurologist is recommended. It is paramount to discuss with patients whether the risk of seizure recurrence is worth the benefit of stopping the antiepileptic drug. The risk of seizure recurrence after antiepileptic drugs are discontinued depends on the epilepsy syndrome and a number of other risk factors. Approximately 30–50% of patients will relapse. If seizures recur, the majority of patients regain seizure control when treatment is resumed. However up to 20% do not achieve immediate remission. NPS MedicineWise 2021-04-01 2021-04 /pmc/articles/PMC8075746/ /pubmed/33911333 http://dx.doi.org/10.18773/austprescr.2021.005 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Aricle Laue-Gizzi, Hanka Discontinuation of antiepileptic drugs in adults with epilepsy |
title | Discontinuation of antiepileptic drugs in adults with epilepsy |
title_full | Discontinuation of antiepileptic drugs in adults with epilepsy |
title_fullStr | Discontinuation of antiepileptic drugs in adults with epilepsy |
title_full_unstemmed | Discontinuation of antiepileptic drugs in adults with epilepsy |
title_short | Discontinuation of antiepileptic drugs in adults with epilepsy |
title_sort | discontinuation of antiepileptic drugs in adults with epilepsy |
topic | Aricle |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075746/ https://www.ncbi.nlm.nih.gov/pubmed/33911333 http://dx.doi.org/10.18773/austprescr.2021.005 |
work_keys_str_mv | AT lauegizzihanka discontinuationofantiepilepticdrugsinadultswithepilepsy |